Oncogenes with potential nuclear function: myc, myb and fos
- PMID: 3779660
Oncogenes with potential nuclear function: myc, myb and fos
Abstract
The protein products of the retroviral oncogenes, v-myc, v-myb and v-fos, and their normal cellular counterparts, the c-myc, c-myb and c-fos proto-oncogenes, have been found to be localized predominantly in the nucleus. In view of the oncogenicity of the retroviral forms of these genes, it is probable that they have central roles in the nuclear events involved in cellular proliferation and differentiation. To investigate these possibilities, detailed studies on the expression of these 'nuclear oncogenes' have been performed. The cellular forms of all three genes are normally expressed in a variety of cell types during proliferation and have RNA and protein products with short half-lives, which is consistent with the idea that they may have regulatory roles. Studies have shown that both c-myc and c-fos are induced during the stimulation of quiescent cells to enter the cell cycle and are continually expressed in replicating cells. In contrast, c-myb levels are greatest in cells as they prepare to enter and traverse S phase. Both c-myc and c-myb expression cease as cells terminally differentiate, whereas in some cell types c-fos is induced during differentiation. Unregulated expression of all three genes has distinct effects on cellular differentiation: myc seems to inhibit differentiation of several cell types when expressed at high levels; myb does not appear to effect differentiation in the systems in which it has been examined; and fos appears to be able to induce differentiation of some cell types. In most cell types, c-myc and c-myb expression is controlled primarily by posttranscriptional mechanisms, whereas c-fos expression is regulated primarily at the transcriptional level. The protein products of these oncogenes are all phosphorylated and probably undergo additional modifications. The nuclear association of these proteins is complex and apparently takes multiple forms. Taken together, these data suggest that all three nuclear oncogenes have distinct regulatory functions with respect to cellular proliferation and differentiation. Several models for function are discussed.
Similar articles
-
Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.J Immunol. 1992 Jul 1;149(1):300-8. J Immunol. 1992. PMID: 1376749
-
Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.J Cell Physiol. 1992 Oct;153(1):147-56. doi: 10.1002/jcp.1041530119. J Cell Physiol. 1992. PMID: 1522128
-
Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.Oncogene. 1989 May;4(5):583-92. Oncogene. 1989. PMID: 2471131
-
Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.Cancer Surv. 1985;4(4):655-81. Cancer Surv. 1985. PMID: 3939686 Review.
-
The myb oncogene.Gene Amplif Anal. 1986;4:73-98. Gene Amplif Anal. 1986. PMID: 3333362 Review.
Cited by
-
Myc oncoproteins are phosphorylated by casein kinase II.EMBO J. 1989 Apr;8(4):1111-9. doi: 10.1002/j.1460-2075.1989.tb03481.x. EMBO J. 1989. PMID: 2663470 Free PMC article.
-
A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C.Mol Cell Biol. 1988 Nov;8(11):4700-6. doi: 10.1128/mcb.8.11.4700-4706.1988. Mol Cell Biol. 1988. PMID: 3062367 Free PMC article.
-
Molecules, cancer, and the surgeon. A review of molecular biology and its implications for surgical oncology.Ann Surg. 1990 Jul;212(1):3-13. doi: 10.1097/00000658-199007000-00002. Ann Surg. 1990. PMID: 2194440 Free PMC article. Review.
-
Current status of tumor markers in large bowel cancer.World J Surg. 1989 Jan-Feb;13(1):52-9. doi: 10.1007/BF01671154. World J Surg. 1989. PMID: 2658354 Review.
-
A critical appraisal of the immunohistochemical detection of the c-myc oncogene product in colorectal cancer.Br J Cancer. 1987 Dec;56(6):779-83. doi: 10.1038/bjc.1987.287. Br J Cancer. 1987. PMID: 3325094 Free PMC article.